Ara
Toplam kayıt 1, listelenen: 1-1
Can eculizumab be discontinued in aHUS? Case report and review of the literature
(Lippincott Williams & Wilkins, 2016)
Background: the management of atypical hemolytic uremic syndrome (aHUS) has evolved into better control of thrombotic microangiopathy (TMA) and recovery of renal functions since the recent introduction of the terminal ...